Active Ingredient: LENACAPAVIR SODIUM
Proprietary Name: SUNLENCA
Dosage Form; Route of Administration: SOLUTION; SUBCUTANEOUS
Strength: EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N215973
Product Number: 001
Approval Date: Dec 22, 2022
Applicant Holder Full Name: GILEAD SCIENCES INC
Marketing Status:
Prescription
Patent and Exclusivity Information
